Real-world Clinical Benefit Evaluation in Breast Cancer Patients With Pharmaceutical Interventions for Cancer-related Fatigue
NCT ID: NCT05428527
Last Updated: 2024-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
261 participants
OBSERVATIONAL
2021-09-08
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Factors Correlated With Fatigue in Breast Cancer
NCT01064427
Pre-operative Therapy in Breast Cancer
NCT05621564
Fatigue As a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option?
NCT04418115
Real-world Study on Shenbailing Granules for Improving Qi and Blood Deficiency in Patients After Breast Cancer Surgery
NCT06881550
Biomarkers of Fatigue Related to Adjuvant Chemotherapy for Breast Cancer
NCT02041364
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breast cancer patients with Cancer-related fatigue treatment
Breast cancer patients who approved to use NHI to pay for Cancer-related fatigue treatment drug
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taichung Veterans General Hospital
OTHER
E-Da Cancer Hospital
UNKNOWN
Chang Gung Memorial Hospital, Taipei
UNKNOWN
Chang Gung Memorial Hospital
OTHER
Tri-Service General Hospital
OTHER
China Medical University Hospital
OTHER
Kaohsiung Medical University Chung-Ho Memorial Hospital
OTHER
Mackay Memorial Hospital
OTHER
Chang Gung Memorial Hospital, Keelung
UNKNOWN
National Defense Medical Center, Taiwan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ming-Shen Dai
Chief of Department of Oncology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
E-Da Cancer Hospital
Kaohsiung City, , Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, , Taiwan
Chang Gung Memorial Hospital, Keelung
Keelung, , Taiwan
China Medical University Hospital
Taichung, , Taiwan
Taichung Veterans General Hospital
Taichung, , Taiwan
Mackay Memorial Hospital
Taipei, , Taiwan
Taipei Chang Gung Memorial Hospital
Taipei, , Taiwan
Tri-Service General Hospital
Taipei, , Taiwan
Linkou Chang Gung Memorial Hospital
Taoyuan District, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRF-NHI01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.